Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-23-009310)

Filing Details

Accession Number:: 0001127602-23-009310
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2023-03-07 16:50:21
Reporting Period:: 2023-03-03

Accepted Time:: 2023-03-07 16:50:21
Original Submission Date:: 2023-03-06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Bausch Health Companies Inc.	BHC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1923756	Seana Carson	400 Somerset Corporate Boulevard Bridgewater NJ 08807	Evp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares, No Par Value	Disposition	2023-03-03	780	$9.34	443,730	No	4	S	Direct
Common Shares, No Par Value	Disposition	2023-03-06	495	$9.17	443,235	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2022.
This Form 4/A is being filed to correct the transaction code originally used to report this transaction on a Form 4 filed by the Reporting Person on 03/06/23. Due to an inadvertent administrative error, this transaction was originally incorrectly reported using code "F" instead of transaction code "S".